Putting the evidence side by side Here is the blunt comparison: AOD 9604: 2.6 kg weight loss in 12 weeks (best result), failed six clinical trials, development terminated Semaglutide: 15 to 17 percent body weight loss over 68 weeks, FDA approved, thousands of study participants, consistent results across multiple trials There is no way to frame this comparison that puts AOD 9604 on equal footing with semaglutide when it comes to clinical evidence
Here is how it works: Step 1: Find the total peptide content listed on your vial
Listen, she is simply amazing
This concept is being studied in an extensive phase 3 program (REDEFINE 1 in obesity, REDEFINE 2 in type 2 diabetes)
At every water volume, the 10mg vial produces exactly double the concentration of the 5mg vial
It is completely absorbed when it is administered parenterally